|
JUND expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.426190E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.112300E-02 |
| Normal-vs-Stage2 |
3.175500E-03 |
| Normal-vs-Stage3 |
1.548630E-01 |
| Normal-vs-Stage4 |
1.638020E-02 |
| Stage1-vs-Stage2 |
3.132500E-02 |
| Stage1-vs-Stage3 |
9.129400E-01 |
| Stage1-vs-Stage4 |
2.416400E-01 |
| Stage2-vs-Stage3 |
6.601700E-02 |
| Stage2-vs-Stage4 |
6.313600E-01 |
| Stage3-vs-Stage4 |
2.760200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.397900E-02 |
| Normal-vs-AfricanAmerican |
2.308200E-02 |
| Normal-vs-Asian |
2.153400E-01 |
| Caucasian-vs-AfricanAmerican |
4.812000E-01 |
| Caucasian-vs-Asian |
5.772600E-01 |
| AfricanAmerican-vs-Asian |
7.385400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.948200E-02 |
| Normal-vs-Female |
1.075810E-02 |
| Male-vs-Female |
2.750800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.571600E-02 |
| Normal-vs-Extreme_Weight |
1.620360E-01 |
| Normal-vs-Obese |
5.341900E-02 |
| Normal-vs-Extreme_Obese |
2.047000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.089800E-01 |
| Normal_Weight-vs-Obese |
7.934200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.995000E-01 |
| Extreme_Weight-vs-Obese |
3.161000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.858400E-01 |
| Obese-vs-Extreme_Obese |
8.830000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.425600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.394250E-02 |
| Normal-vs-Age(61-80Yrs) |
4.702400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.103300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.031500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.297020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.442250E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.063200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.670300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.718280E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.908990E-01 |
| Normal-VS-Type2 PRCC |
2.637100E-03 |
| Normal-VS-KIRP CIMP |
4.516200E-01 |
| Normal-VS-Unclassified PRCC |
1.877530E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.415100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.893400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.033700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.032750E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.845200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.904000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.610020E-02 |
| Normal-vs-N1 |
1.904210E-01 |
| Normal-vs-N2 |
6.705000E-01 |
| N0-vs-N1 |
3.095800E-01 |
| N0-vs-N2 |
3.837000E-01 |
| N1-vs-N2 |
7.944800E-01 |
|
|
